Stockscreener 앱 받기
26.33
0.34%
0.09
시간 외 거래:
26.33
Pacira Biosciences Inc 주식(PCRX)의 최신 뉴스
Pacira upgraded at Truist citing end to eVenus patent dispute - MSN
Nisa Investment Advisors LLC Boosts Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World
Pacira BioSciences (NASDAQ:PCRX) Stock Rating Upgraded by Truist Financial - Defense World
Pacer Advisors Inc. Lowers Position in Pacira BioSciences, Inc. (NASDAQ:PCRX) - MarketBeat
Lowey Dannenberg Notifies Pacira Biosciences, Inc. - GlobeNewswire
PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira - PR Newswire
Pacira BioSciences soars 62% following InvestingPro's October Fair Value alert - MSN
PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit - PR Newswire
PCRX Stockholders Should Contact Shareholder Rights Firm - GlobeNewswire
PCRX Stockholders Should Contact Shareholder Rights Firm Robbins for Information About the Class Action Against Pacira BioSciences, Inc. - GlobeNewswire Inc.
Pacira BioSciences soars 62% following InvestingPro's October Fair Value alert By Investing.com - Investing.com Canada
Investors in Pacira BioSciences, Inc. Should Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your RightsPCRX - Victoria Advocate
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira - PR Newswire
What 8 Analyst Ratings Have To Say About Pacira BioSciences - Benzinga
Pacira BioSciences stock upgraded at Truist (PCRX:NASDAQ) - Seeking Alpha
PCRX LAWSUIT ALERT: Levi & Korsinsky Notifies Pacira - GlobeNewswire
Pacira Announces Updates to Board of Directors - GlobeNewswire
Pacira Pharmaceuticals Implements New Board Leadership for Growth - TipRanks
Pacira's Massive Board Overhaul: Industry Veteran Takes Helm as 5 New Directors Join - StockTitan
PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
Truist Upgrades Pacira Biosciences to Hold From Sell, Boosts Price Target to $25 From $8 - Marketscreener.com
Pacira BioSciences (NASDAQ:PCRX) Has A Rock Solid Balance Sheet - Simply Wall St
The Gross Law Firm Notifies Shareholders of Pacira BioSciences, Inc. (PCRX) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
PCRX Shareholders Have Opportunity to Lead Pacira BioSciences, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - Markets Insider
Investors in Pacira BioSciences, Inc. Should Contact The - GlobeNewswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira - GlobeNewswire
PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - Markets Insider
PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - GlobeNewswire Inc.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Pacira Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesPCRX - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira BioSciences, Inc. LawsuitPCRX - Morningstar
ROSEN, A LEADING LAW FIRM, Encourages Pacira BioSciences, - GlobeNewswire
(PCRX) Trading Signals - Stock Traders Daily
Pacira BioSciences, Inc. Securities Fraud Class Action - GlobeNewswire
PCRX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Rosen Law Firm Reminds Pacira Investors of Class Action Lawsuit Deadline - Lawyer Monthly Magazine
Investors in Pacira BioSciences, Inc. Should Contact The Gross Law Firm Before March 14, 2025 to Discuss Your RightsPCRX - PR Newswire
PCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Pacira BioSciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
Pacira BioSciences (NASDAQ:PCRX) Trading Up 4.7%Should You Buy? - MarketBeat
PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
ROSEN, LEADING INVESTOR COUNSEL, Encourages Pacira - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure ... - The Hastings Tribune
Pacira BioSciences Inc (PCRX) Shares Up 5.44% on Jan 24 - GuruFocus.com
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Pacira BioSciences, Inc.(PCRX) Shareholders - Morningstar
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira - Marketscreener.com
Investors who lost money on Pacira BioSciences, Inc.(PCRX) shoul - GuruFocus.com
Investors who lost money on Pacira BioSciences, Inc.(PCRX) should contact The Gross Law Firm about pending Class ActionPCRX - PR Newswire
PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF - The Bakersfield Californian
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira - GlobeNewswire
PCRX Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Pacira BioSciences, Inc. - Markets Insider
Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives $24.50 Average Price Target from Analysts - Defense World
PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira Lawsuit – PCRX - GlobeNewswire
PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & ... - The Bakersfield Californian
PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel - The Bakersfield Californian
Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments - GlobeNewswire
PCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
1.19%
0.06%
자본화:
|
볼륨(24시간):